<DOC>
	<DOCNO>NCT01010906</DOCNO>
	<brief_summary>This 3-part study compare pharmacokinetics administration vaniprevir ( MK-7009 ) participant mild , moderate severe hepatic insufficiency healthy match control participant . The primary hypothesis area curve ( AUC ) ( 0 infinity ) vaniprevir participant mild , moderate , severe hepatic insufficiency similar observe healthy match controlled participant .</brief_summary>
	<brief_title>A Study Investigating Influence Hepatic Insufficiency Pharmacokinetics Vaniprevir ( MK-7009-005 )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatic Insufficiency</mesh_term>
	<criteria>Hepatic Participants : Females reproductive potential test negative pregnancy agree use appropriate method contraception study Apart hepatic insufficiency , good general health Has diagnosis chronic stable hepatic insufficiency Score ChildPugh scale range 5 6 ( mild hepatic insufficiency ) ; 7 9 ( moderate hepatic insufficiency ) ; 10 15 ( severe hepatic insufficiency ) . Moderate Severe participant must 50 % score 2 high least one laboratory parameter ( i.e. , albumin , prothrombin time , bilirubin ) prestudy visit . Healthy Matched Participants : Females reproductive potential test negative pregnancy agree use appropriate method contraception study Is good health Female pregnant , lactating , expect become pregnant donate egg Has history stroke seizures Has history cancer Is unable refrain use prescription nonprescription medication Consumes excessive amount alcohol caffeinated beverage daily Has surgery , donate blood participate another investigational study last 4 week Is regular user past abuser illicit drug include alcohol</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>